A Novel Cardioprotective Agent in Cardiac Transplantation: Metformin Activation of AMP-Activated Protein Kinase Decreases Acute Ischemia-Reperfusion Injury and Chronic Rejection

The main cause of mortality after the first year from cardiac transplantation is cardiac allograft vasculopathy (CAV), which leads to chronic rejection of the heart. To improve long-term outcomes in cardiac transplantation, treatments to prevent or diminish CAV are actively being researched. Ischemi...

Descripción completa

Detalles Bibliográficos
Autores principales: Chin, Jocelyn T., Troke, Joshua J., Kimura, Naoyuki, Itoh, Satoshi, Wang, Xi, Palmer, Owen P., Robbins, Robert C., Fischbein, Michael P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: YJBM 2011
Materias:
Original Contribution
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238328/
https://www.ncbi.nlm.nih.gov/pubmed/22180679

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3238328/
https://www.ncbi.nlm.nih.gov/pubmed/22180679

Ejemplares similares